Dr. Heather Leigh Hofflich, DO

Dr. Hofflich practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Hofflich's NPI, 1598962102, was assigned on June 27, 2007. Dr. Hofflich graduated from Pcom in 2001. Dr. Hofflich holds California license 20A8966.

Dr. Hofflich's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Hofflich's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Hofflich is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Hofflich to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hofflich practices, 2 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Hofflich's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Hofflich is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dr. Hofflich is licensed in California.

Dmand AI lists acid reflux, adjustment disease, alzheimer's disease, anxiety, arthritis, asthma, atrial fibrillation and flutter and chronic diabetes among the conditions Dr. Hofflich treats.

CMS data shows 964 Medicare services from Dr. Hofflich across 13 procedure codes in 2024, for 422 Medicare patients. Medicare paid $71,841 for them. Every service was in an office.

CMS counts 422 Medicare patients who saw Dr. Hofflich in 2024. The largest group is 65 to 74, with 185 patients. 75% of them have high cholesterol, and 65% have osteoporosis. 10% are also on Medicaid. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hofflich's median patient age at 66, with 76% women.

In 2024, Dr. Hofflich wrote 3,488 Medicare Part D claims for 400 patients. 80% of them were for generic drugs. CMS names the drug for 2,906 of them, across 76 drugs with 11 or more claims each, at $888,741 in total drug cost. In 2023, CMS named 2,633 claims across 65 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Hofflich for performance year 2024, reported as part of a group. Dr. Hofflich accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hofflich as offering telehealth.

Dmand AI links 25 papers to Dr. Hofflich, published from 2012 to 2025. 2014 was the busiest year, with 2. The most frequent topics are Vitamin D, Vitamin D Deficiency and Cancer Survivors. Dr. Hofflich has published most often in J Hepatol. Dr. Hofflich's most frequent co-authors are Aditya Bagrodia, MD, Juan Francisco Javier-Desloges, MD and Rohit Loomba, MD.

CMS Open Payments shows 72 general payments to Dr. Hofflich from 9 drug and device companies from 2016 to 2020. Speaker and faculty fees make up the largest share, 72% of the total. Radius Health, Inc. paid the most, $18,760.

Dmand AI lists 8 awards for Dr. Hofflich, most recently Larry Friedman Mentorship Award in 2023.

Dr. Hofflich graduated from Pcom in 2001. Dr. Hofflich is a member of AACE, AOA, ENDO and National Osteoporosis Foundation.

Dr. Hofflich is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.